CXCR3 predicts the prognosis of endometrial adenocarcinoma

OBJECTIVES: Currently, endometrial adenocarcinoma lacks an effective prognostic indicator. This study was to develop and validate a gene biomarker and a nomogram to predict the survival of endometrial adenocarcinoma, explore potential mechanisms and select sensitive drugs. METHODS: 425 endometrial a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, He, Sun, Mengzi, Li, Hua, Yue, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903462/
https://www.ncbi.nlm.nih.gov/pubmed/36750966
http://dx.doi.org/10.1186/s12920-023-01451-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903462/
https://www.ncbi.nlm.nih.gov/pubmed/36750966
http://dx.doi.org/10.1186/s12920-023-01451-9

Ejemplares similares